期刊文献+

复方环磷腺苷乳膏毒性研究 被引量:1

Toxic experimental study of compound cream of adenosine cyclophosphate
下载PDF
导出
摘要 目的:考察复方环磷腺苷乳膏经皮肤给药的安全性。方法:将不同剂量的复方环磷腺苷乳膏和基质用于白色豚鼠背部正常或破损去毛区皮肤,观察皮肤急性毒性、刺激性反应和动物的过敏情况。结果:复方环磷腺苷乳膏未产生急性毒性反应;反复致敏后使用,也无皮肤与全身过敏反应;一次或多次给药对豚鼠正常皮肤无刺激性。对破损皮肤有轻度刺激性,但给药后48 h或72 h,这种刺激性消失。结论:复方环磷腺苷乳膏未产生急性毒性和过敏反应,也无明显刺激性反应。 Objective :To investigate the safety of compound adenosine cyclophosphate cream (CACC) on ani- mals. Methods: The depilated areas of intact skin or dermal injury skin of white guinea pigs were smeared with different dosages of CACC and the ground substance of the cream. Acute toxic skin reactions, skin irritation and skin allergic reaction were kept under observation. Results: Neither acute toxic effects nor allergic skin or sys- tematic reactions in intact or injured skin were induced by applications of CACC. No irritant dermal reaction were observed in intact skin, while slight irritation reactions were observed in the animals after the single or repeated applications of CACC, which faded away 48 h or 72 h afterwards. Conlusions: CACC was shown to exert no apparent irritant, toxic effects or allergic skin reactions in guinea pigs.
出处 《药学与临床研究》 2007年第5期377-379,共3页 Pharmaceutical and Clinical Research
关键词 复方环磷腺苷乳膏 急性毒性 皮肤过敏 刺激性反应 Compound adenosine cyclophosphate cream ( CACC ) Acute toxicity Skin allergy Irritant reaction
  • 相关文献

参考文献4

二级参考文献31

  • 1孙旭光.药物新制剂大全[M].哈尔滨:黑龙江科学技术出版社,1995.275.
  • 2van de Kerkhof PC, Vissers WH. The topical treatment of psoriasis. Skin Pharmacol Appl Skin Physiol, 2003, 16: 69-83.
  • 3Liem WH, McCullough JL, Weinstein GD.Effectiveness of topical therapy for psoriasis: results of a national survey. Cutis.1995, 55: 306-310.
  • 4Gollnick H, Menter A. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol, 1999, 140 Suppl 54: 18-23.
  • 5Grattan CE, Christopher AP, Robinson M,et al. Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis. Br J Dermatol, 1988, 119: 623-626.
  • 6Swinkels OQ, Prins M, Kucharekova M, et al. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. Br J Dermatol, 2002,146: 621-626.
  • 7Swinkels OQ, Prins M, Tosserams EF, et al.The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.Br J Dermatol, 2001, 145: 63-69.
  • 8Koo J, Cuffie CA, Tanner DJ, et al.Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.Clin Ther, 1998, 20: 283-291.
  • 9Monastirli A, Georgiou S, Pasmatzi E, et al,Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis. Skin Pharmacol Appl Skin Physiol, 2002, 15: 246-251.
  • 10Bowman PH, Maloney JE, Koo JY. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study. J Am Acad Dermatol, 2002, 46: 907-913.

共引文献37

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部